Start Date
April 29, 2019
Primary Completion Date
August 22, 2019
Study Completion Date
August 22, 2019
venetoclax
tablet; oral
lenalidomide
capsule; oral
dexamethasone
tablet; oral
Westmead Hospital /ID# 210267, Westmead
St. Vincents Hosp Melbourne /ID# 210266, Fitzroy
Austin Hospital /ID# 210268, Heidelberg
Monash Medical Centre /ID# 210269, Melbourne
Flinders Centre for Innovation /ID# 210697, Bedford Park
UPMC Hillman Cancer Ctr /ID# 208121, Pittsburgh
Duke University Hospital /ID# 208306, Durham
Hspital Universitario Gregorio Maranon /ID# 209926, Madrid
Clinica Universitar de Navarra - Madrid /ID# 210131, Madrid
Hosp Univ 12 de Octubre /ID# 209887, Madrid
Clinica Universitar de Navarra - Pamplona /ID# 209883, Pamplona
Hospital Univ Dr. Peset /ID# 209884, Valencia
Karmanos Cancer Institute /ID# 208805, Detroit
Henry Ford Hospital /ID# 208481, Detroit
University of California, Los Angeles /ID# 208516, Los Angeles
City of Hope /ID# 212211, Duarte
Marin Cancer Care /ID# 208476, Greenbrae
Tom Baker Cancer Centre /ID# 208549, Calgary
Princess Margaret Cancer Centr /ID# 208923, Toronto
Hopital Maisonneuver-Rosemont /ID# 208550, Montreal
McGill Univ HC /ID# 208486, Montreal
Hospital Clinic de Barcelona /ID# 209888, Barcelona
Lead Sponsor
Collaborators (2)
Genentech, Inc.
INDUSTRY
Celgene Corporation
INDUSTRY
AbbVie
INDUSTRY